Published in Am J Clin Nutr on August 01, 2005
Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr (2006) 13.19
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90
Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav (2010) 3.66
So depression is an inflammatory disease, but where does the inflammation come from? BMC Med (2013) 2.02
Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages. Curr Diab Rep (2012) 1.52
Demographic and behavioral factors associated with daily sugar-sweetened soda consumption in New York City adults. J Urban Health (2008) 1.52
Review of the nutritional benefits and risks related to intense sweeteners. Arch Public Health (2015) 1.40
Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. J Am Coll Cardiol (2015) 1.14
Fructose: pure, white, and deadly? Fructose, by any other name, is a health hazard. J Diabetes Sci Technol (2010) 1.12
Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr (2013) 1.09
The emerging role of dietary fructose in obesity and cognitive decline. Nutr J (2013) 1.05
Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know? Adv Nutr (2013) 1.02
Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women. Am J Clin Nutr (2014) 0.90
Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J (2014) 0.89
Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men. Am Heart J (2007) 0.86
Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial. Food Nutr Res (2011) 0.86
Fructose-containing sugars and cardiovascular disease. Adv Nutr (2015) 0.82
Cognitive performance of Göttingen minipigs is affected by diet in a spatial hole-board discrimination test. PLoS One (2013) 0.80
Sugar Sweetened Beverage Consumption among Adults with Gout or Type 2 Diabetes. PLoS One (2015) 0.80
Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden. Eur J Nutr (2015) 0.79
Potential health risks from beverages containing fructose found in sugar or high-fructose corn syrup. Diabetes Care (2013) 0.77
Added sugars and risk factors for obesity, diabetes and heart disease. Int J Obes (Lond) (2016) 0.76
Saturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk. Healthcare (Basel) (2017) 0.76
A four-day Western-style dietary intervention causes reductions in hippocampal-dependent learning and memory and interoceptive sensitivity. PLoS One (2017) 0.75
Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study. Am J Epidemiol (2015) 0.75
Does sucrose intake affect antropometric variables, glycemia, lipemia and C-reactive protein in subjects with type 1 diabetes?: a controlled-trial. Diabetol Metab Syndr (2013) 0.75
Sugar-Sweetened Beverage but Not Diet Soda Consumption Is Positively Associated with Progression of Insulin Resistance and Prediabetes. J Nutr (2016) 0.75
Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding. Nutrients (2016) 0.75
Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey. Dermatol Ther (Heidelb) (2017) 0.75
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med (2015) 11.05
Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med (2010) 5.86
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet (2007) 5.49
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet (2010) 5.44
Myths, presumptions, and facts about obesity. N Engl J Med (2013) 5.39
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis (2007) 3.70
Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr (2002) 3.25
No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr (2004) 3.08
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab (2003) 2.71
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr (2011) 2.47
Sleep restriction is not associated with a positive energy balance in adolescent boys. Am J Clin Nutr (2012) 2.38
Protein, weight management, and satiety. Am J Clin Nutr (2008) 2.34
Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol (2013) 2.18
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J (2006) 2.12
Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr (2008) 1.97
Video game playing increases food intake in adolescents: a randomized crossover study. Am J Clin Nutr (2011) 1.92
Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation (2011) 1.88
Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes Rev (2008) 1.80
The use of glycaemic index tables to predict glycaemic index of composite breakfast meals. Br J Nutr (2004) 1.74
Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care (2007) 1.74
High levels of industrially produced trans fat in popular fast foods. N Engl J Med (2006) 1.74
Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev (2010) 1.71
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr (2011) 1.66
Effect of protein intake on bone mineralization during weight loss: a 6-month trial. Obes Res (2002) 1.64
A trans world journey. Atheroscler Suppl (2006) 1.61
Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol (2009) 1.52
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J (2005) 1.50
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med (2009) 1.49
FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One (2008) 1.49
Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab (2006) 1.49
Effect of trans-fatty acid intake on insulin sensitivity and intramuscular lipids--a randomized trial in overweight postmenopausal women. Metabolism (2011) 1.47
The use of glycaemic index tables to predict glycaemic index of breakfast meals. Br J Nutr (2005) 1.45
Measuring the glycemic index of foods: interlaboratory study. Am J Clin Nutr (2008) 1.44
Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr (2003) 1.44
[The CARMEN trial: increased intake of carbohydrates--simple or complex--and unchanged blood lipids in overweight subjects]. Ugeskr Laeger (2002) 1.40
Long-term effects on haemostatic variables of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals. Br J Nutr (2010) 1.38
Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab (2010) 1.35
Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. Obes Res (2005) 1.26
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol (2003) 1.26
The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care (2004) 1.24
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J (2004) 1.24
Diet composition and obesity. Lancet (2012) 1.23
Starches, sugars and obesity. Nutrients (2011) 1.23
Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies. Br J Nutr (2007) 1.23
Fat oxidation before and after a high fat load in the obese insulin-resistant state. J Clin Endocrinol Metab (2006) 1.21
Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Obes Facts (2008) 1.17
Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr (2002) 1.17
Major increase in prevalence of overweight and obesity between 1987 and 2001 among Danish adults. Obes Res (2004) 1.14
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Am Heart J (2004) 1.12
Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. Am J Clin Nutr (2009) 1.12
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J (2002) 1.11
Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. Am J Clin Nutr (2007) 1.11
Whole grain and body weight changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am J Clin Nutr (2013) 1.11
Food intake is inhibited by oral oleoylethanolamide. J Lipid Res (2004) 1.11
Seasonal variation in objectively measured physical activity, sedentary time, cardio-respiratory fitness and sleep duration among 8-11 year-old Danish children: a repeated-measures study. BMC Public Health (2013) 1.10
Effect on 24-h energy expenditure of a moderate-fat diet high in monounsaturated fatty acids compared with that of a low-fat, carbohydrate-rich diet: a 6-mo controlled dietary intervention trial. Am J Clin Nutr (2007) 1.09
Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609. J Clin Endocrinol Metab (2008) 1.09
[N-3 polyunsaturated acids and cardiovascular disease. Cochrane analysis with unclear conclusions]. Ugeskr Laeger (2005) 1.09
Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety. Am J Clin Nutr (2013) 1.09
The satiating power of protein--a key to obesity prevention? Am J Clin Nutr (2005) 1.08
Guidelines for the New Nordic Diet. Public Health Nutr (2012) 1.08
Weight loss as treatment for knee osteoarthritis symptoms in obese patients: 1-year results from a randomised controlled trial. Ann Rheum Dis (2011) 1.07
Design of the OPUS School Meal Study: a randomised controlled trial assessing the impact of serving school meals based on the New Nordic Diet. Scand J Public Health (2012) 1.07
On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans. Am J Physiol Endocrinol Metab (2009) 1.06
Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc (2005) 1.06
Ruminant and industrially produced trans fatty acids: health aspects. Food Nutr Res (2008) 1.05
The effect of protein and glycemic index on children's body composition: the DiOGenes randomized study. Pediatrics (2010) 1.05
Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: a review of the evidence from controlled clinical trials. Adv Nutr (2013) 1.05
Whole grain compared with refined wheat decreases the percentage of body fat following a 12-week, energy-restricted dietary intervention in postmenopausal women. J Nutr (2012) 1.04
Altered fat tissue distribution in young adult men who had low birth weight. Diabetes Care (2005) 1.04
Dietary composition and nutrient content of the New Nordic Diet. Public Health Nutr (2012) 1.04
Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation (2004) 1.02
Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr (2008) 1.02
Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. Clin Pharmacol Ther (2002) 1.01
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol (2012) 1.00
Haemostatic reference intervals in pregnancy. Thromb Haemost (2010) 1.00
Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res (2003) 0.99
Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med (2010) 0.99
Health effect of the New Nordic Diet in adults with increased waist circumference: a 6-mo randomized controlled trial. Am J Clin Nutr (2013) 0.98
Reproducibility and power of ad libitum energy intake assessed by repeated single meals. Am J Clin Nutr (2008) 0.97
Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One (2009) 0.97
Weight maintenance through behaviour modification with a cooking course or neurolinguistic programming. Can J Diet Pract Res (2011) 0.97
Adipose tissue transcriptome reflects variations between subjects with continued weight loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr (2010) 0.97